HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Sylvie Romain Selected Research
Sylvie Romain Research Topics
Disease
7
Neoplasms (Cancer)
01/2022 - 01/2002
6
Breast Neoplasms (Breast Cancer)
06/2015 - 01/2002
1
Glioblastoma (Glioblastoma Multiforme)
01/2022
1
Carcinoma (Carcinomatosis)
09/2004
1
Ductal Carcinoma
09/2004
1
Colorectal Neoplasms (Colorectal Cancer)
09/2002
1
Aneuploidy (Aneuploid)
06/2002
1
Necrosis
03/2002
1
Glioma (Gliomas)
03/2002
1
Neoplasm Metastasis (Metastasis)
01/2002
Drug/Important Bio-Agent (IBA)
4
Urokinase-Type Plasminogen Activator (Urokinase)
FDA Link
06/2011 - 01/2002
4
Plasminogen Activator Inhibitor 1
IBA
01/2011 - 01/2002
2
Biomarkers (Surrogate Marker)
IBA
01/2022 - 01/2002
2
Hormones (Hormone)
IBA
06/2015 - 01/2002
2
Cathepsin D
IBA
06/2011 - 01/2011
2
Plasminogen Activators (Plasminogen Activator)
IBA
06/2011 - 03/2002
2
Estrogen Receptors
IBA
06/2011 - 01/2011
2
Peptide Hydrolases (Proteases)
FDA Link
06/2011 - 01/2011
2
Plasminogen Inactivators
IBA
01/2011 - 03/2002
1
Bevacizumab (Avastin)
FDA Link
01/2022
1
Matrix Metalloproteinase 2 (Gelatinase A)
IBA
01/2022
1
Messenger RNA (mRNA)
IBA
01/2022
1
Thymidine Kinase
IBA
06/2011
1
Plasminogen
IBA
01/2011
1
Amphiregulin
IBA
09/2004
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
09/2004
1
Capecitabine (Xeloda)
FDA Link
09/2002
1
Tyrosine Kinase Inhibitors
IBA
07/2002
1
DNA (Deoxyribonucleic Acid)
IBA
06/2002
1
Biological Factors
IBA
03/2002
1
Tissue Extracts
IBA
01/2002
1
Steroids
IBA
01/2002
Therapy/Procedure
2
Therapeutics
06/2015 - 10/2010